Under normoxia, mitochondrial metabolism in cancer cells may be favored because mTOR triggers mitochondrial biogenesis through TFAM and PGC1-α activation [120]; in addition, mTOR may upregulate glycolysis through HIF-1α activation [75] (Figure 3A). Here, PPARGC1A is linked to cancer.